Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs9982601
rs9982601 		0.820 GeneticVariation BEFREE Two other SNPs on the same gene, rs10757274_G [0.79(0.73-0.86); p = 2.98E-08] and rs1333045_C [0.79(0.73-0.86); p = 1.15E-08] as well as the rs9982601_T [1.38(1.23-1.55); p = 3.49E-08] on KCNE2 were associated with MI. 26708285

2016
dbSNP: rs9982601
rs9982601 		T 0.820 GeneticVariation GWASDB Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. 19198609

2009
dbSNP: rs9982601
rs9982601 		T 0.820 GeneticVariation GWASCAT Two other SNPs on the same gene, rs10757274_G [0.79(0.73-0.86); p = 2.98E-08] and rs1333045_C [0.79(0.73-0.86); p = 1.15E-08] as well as the rs9982601_T [1.38(1.23-1.55); p = 3.49E-08] on KCNE2 were associated with MI. 26708285

2016
dbSNP: rs9982601
rs9982601 		0.820 GeneticVariation BEFREE We showed that the rs9982601 polymorphism of the region between SLC5A3/MRPS6 and KCNE2 genes is associated with long-term mortality in high-risk patients after MI. 25697262

2015
dbSNP: rs9982601
rs9982601 		T 0.820 GeneticVariation GWASCAT Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. 19198609

2009
dbSNP: rs11206510
rs11206510 		0.810 GeneticVariation BEFREE Two-sided <i>P</i> values <0.05 were considered significant.<b>Results:</b> We observed a significant interaction between the <i>PCSK9</i> rs11206510 genotype and LC n-3 PUFA intake on nonfatal MI risk (<i>P</i>-interaction = 0.012). 28330911

2017
dbSNP: rs11206510
rs11206510 		T 0.810 GeneticVariation GWASCAT Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. 19198609

2009
dbSNP: rs11206510
rs11206510 		T 0.810 GeneticVariation GWASCAT A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. 26343387

2015
dbSNP: rs11206510
rs11206510 		T 0.810 GeneticVariation GWASDB Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. 19198609

2009
dbSNP: rs11748327
rs11748327 		0.800 GeneticVariation GWASDB SNPs on chromosome 5p15.3 associated with myocardial infarction in Japanese population. 21107343

2011
dbSNP: rs11748327
rs11748327 		0.800 GeneticVariation GWASCAT SNPs on chromosome 5p15.3 associated with myocardial infarction in Japanese population. 21107343

2011
dbSNP: rs1746048
rs1746048 		C 0.800 GeneticVariation GWASDB Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. 19198609

2009
dbSNP: rs1746048
rs1746048 		C 0.800 GeneticVariation GWASCAT Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. 19198609

2009
dbSNP: rs6941513
rs6941513 		0.710 GeneticVariation BEFREE Four SNPs near QKI showed nominally significant association with MI (p-value<8.8×10-3) and three exceeded the genome-wide significance threshold when Stage I and Stage II results were combined (top SNP rs6941513: p = 6.2×10-9). 26950853

2016
dbSNP: rs6941513
rs6941513 		G 0.710 GeneticVariation GWASCAT Four SNPs near QKI showed nominally significant association with MI (p-value<8.8×10-3) and three exceeded the genome-wide significance threshold when Stage I and Stage II results were combined (top SNP rs6941513: p = 6.2×10-9). 26950853

2016
dbSNP: rs10176176
rs10176176 		T 0.700 GeneticVariation GWASCAT A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. 26343387

2015
dbSNP: rs117714106
rs117714106 		T 0.700 GeneticVariation GWASCAT Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib. 28753643

2017
dbSNP: rs1544935
rs1544935 		T 0.700 GeneticVariation GWASCAT A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. 26343387

2015
dbSNP: rs1870634
rs1870634 		G 0.700 GeneticVariation GWASCAT A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. 26343387

2015
dbSNP: rs2001846
rs2001846 		T 0.700 GeneticVariation GWASCAT A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. 26343387

2015
dbSNP: rs201052613
rs201052613 		0.700 GeneticVariation GWASCAT Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib. 28753643

2017
dbSNP: rs2019090
rs2019090 		A 0.700 GeneticVariation GWASCAT A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. 26343387

2015
dbSNP: rs2315065
rs2315065 		A 0.700 GeneticVariation GWASCAT A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. 26343387

2015
dbSNP: rs28451064
rs28451064 		A 0.700 GeneticVariation GWASCAT A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. 26343387

2015
dbSNP: rs4593108
rs4593108 		C 0.700 GeneticVariation GWASCAT A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. 26343387

2015